NCT06722417View on ClinicalTrials.gov

A Single Dose Study to Assess Adverse Events and How Oral Icalcaprant Moves Through the Body in Healthy Adult Japanese and Han Chinese Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 26, 2024

Primary Completion Date

January 17, 2025

Study Completion Date

January 17, 2025

Conditions
Healthy Volunteer
Interventions
DRUG

Icalcaprant

Oral capsules

Trial Locations (1)

92801

Anaheim Clinical Trials, LLC /ID# 271323, Anaheim

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY